FGU Russian Scientific Research Institute of Hematology and Transfusiology

Saint Petersburg 191024

0 studies enrolling now · 3 studies all time

What they study most

Indolent Non-Hodgkin's Lymphomas, Multiple Myeloma, Myeloid Leukemia, Chronic, Chronic Phase

Studies at this site

• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early